- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06416943
3D Port-A Catheter Model for New Staff
Effects of a 3D-Printed Port-A Catheter Model Training Course for New Staff
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Cancer patients often require long-term administration of chemotherapy drugs, nutritional supplementation, and blood transfusions. During these treatments, an implantable central venous access (port-a catheter) is often utilized to avoid the inconvenience of repeated needle insertions for treatment and to minimize the risk of medication leakage. Port-A catheters are considered a safer clinical measure. However, poor care and maintenance of the catheter can lead to complications such as infection, catheter damage, and leakage, which can even result in death. Proper care and maintenance are crucial for the successful use of Port-A catheters. For nursing staff, acquiring professional knowledge in Port-A catheter care is essential for improving the quality of cancer patient care. Insufficient education and training in Port-A catheter care can lead to clinical errors that endanger patients' lives.
Methods: This study involves providing training to participants and assessing their performance and effectiveness. It employs a prospective quasi-experimental design with a single group and pre- and post-test evaluations. The study includes 50 newly recruited nursing staff.
Effect: The investigators anticipate that the use of a 3D-printed upper body Port-A catheter model will yield better results in the training of newly recruited nursing staff.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ke-Yun Chao, PhD
- Phone Number: +886-905-301-879
- Email: C00152@mail.fjuh.fju.edu.tw
Study Locations
-
-
-
New Taipei City, Taiwan, 24352
- Fu Jen Catholic University Hospital, Fu Jen Catholic University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- New nursing staff joined Fu Jen Catholic University Hospital.
Exclusion Criteria:
- Refused to participate in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 3D medical education model group
Received a regular learning plus 3D printing model
|
Slide-based presention plus 3D printed port-A catheter model
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Examination score of pre-intervention
Time Frame: pre-intervention
|
score of pre-intervention (maximun 100 and minimum 0), higher means a better outcome.
|
pre-intervention
|
|
Examination score of post-intervention
Time Frame: immediately after the intervention
|
score of post-intervention (maximun 100 and minimum 0), higher means a better outcome.
|
immediately after the intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ke-Yun Chao, PhD, Fu Jen Catholic University Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FJUH112278-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.